ANKS1A and Alzheimer disease: However, as the amyloid levels in the endothelial vessels are also increased with immunotherapy, it is worth to test whether a combination of anti-Aβ immunotherapy with AAV-ANKS1A gene therapy would improve the effectiveness of such immunotherapy in AD-like animal models.